Ninety days of intermittent cannabinoid treatment in an Alzheimer's mouse model reduced anxiety, partially reversed cognitive deficits, decreased amyloid plaque deposits, and lowered brain glucose metabolism.
Alzheimer's researchers, neurologists, and those interested in cannabinoid neuroprotection
Reduced amyloid plaque number and size after 90-day treatment
What the researchers found
Chronic treatment with JWH-133 (a selective CB2 agonist) and Cannabis sativa extract reduced anxiety-like behavior and partially reversed recognition memory deficits in APP/PS1 mice. Both treatments reduced the number and size of amyloid-beta plaque deposits, decreased cerebral glucose metabolism, reduced mTOR and CB2 receptor expression, and enhanced M1 muscarinic acetylcholine receptor expression.
Why it matters
Alzheimer's disease has no effective treatment despite decades of research. The finding that cannabinoid receptor ligands can reduce plaque deposits and improve cognition in an Alzheimer's model, through the expanded endocannabinoid system, opens a new therapeutic avenue worth pursuing.
The numbers in context
Treatment: 90 days intermittent. JWH-133: 0.2 mg/kg. Cannabis extract: 2.5 mg/kg. Outcomes: reduced anxiety, partially reversed cognitive deficits, reduced amyloid-beta plaque number and size, decreased cerebral glucose metabolism, reduced mTOR and CB2 expression, increased M1 mAChR expression.
How the study worked
APP/PS1 transgenic mice (Alzheimer's model) received 90 days of intermittent treatment with JWH-133 (0.2 mg/kg) or EU-GMP certified Cannabis sativa (Cannabixir Medium Flos, 2.5 mg/kg). Recognition memory, anxiety behavior, brain imaging, and molecular markers were assessed.
What this study cannot tell us
Mouse model findings often do not translate to human Alzheimer's. APP/PS1 mice only model the amyloid component of Alzheimer's, not the full disease. The treatment regimen (90 days intermittent) may not represent practical clinical dosing. No long-term follow-up.
How to read the evidence
Well-designed preclinical study with multiple outcome measures, but animal model findings require human validation.
When this study was published
2024 study
The bigger picture
The endocannabinoid system is increasingly recognized as a modulator of neuroinflammation and neurodegeneration. That both a selective CB2 agonist and a full cannabis extract showed similar benefits suggests the CB2 receptor pathway may be a key therapeutic target for Alzheimer's.
Questions still open
- Would CB2-selective agonists work in humans with Alzheimer's? Can cannabinoid treatment halt or just slow plaque accumulation? What is the role of the mTOR pathway reduction in the observed benefits?
Common questions
Could cannabinoids help with Alzheimer's disease?
Which cannabinoid receptors are involved in Alzheimer's?
Read the original research
Exploring Cannabinoids with Enhanced Binding Affinity for Targeting the Expanded Endocannabinoid System: A Promising Therapeutic Strategy for Alzheimer's Disease Treatment.
Pharmaceuticals (Basel, Switzerland), 17(4)
Citation
Stanciu, Gabriela Dumitrita; Ababei, Daniela-Carmen; Solcan, Carmen; Uritu, Cristina-Mariana; Craciun, Vlad-Constantin; Pricope, Cosmin-Vasilica; Szilagyi, Andrei; Tamba, Bogdan-Ionel. (2024). Exploring Cannabinoids with Enhanced Binding Affinity for Targeting the Expanded Endocannabinoid System: A Promising Therapeutic Strategy for Alzheimer's Disease Treatment.. Pharmaceuticals (Basel, Switzerland), 17(4). https://doi.org/10.3390/ph17040530
Explore the wider topic
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Your Nervous System After Quitting Weed: Fight or Flight
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)